The Food and Drug Administration (FDA) has approved the following mediations for the treatment of
opioid use disorder:
- Methadone
- Buprenorphine
- Naltrexone
Unfortunately, no medications have been approved for the treatment of cannabis, hallucinogen, or
stimulant use disorders.